Literatur
- 1 Blackstock T.. Tacrolimus music to transplant recipient's ears: the SYMPHONY trial. Inpharma
2006: 15-19
- 2
Ciancio G, Burke GW, Gaynor JJ. et al. .
A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate
mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug
interactions and rejection at one year.
Transplantation.
2004;
77
244-251
- 3
Gonwa T, Johnson C, Ahsan N. et al. .
Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine
+ mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
Transplantation.
2003;
75
2048-2053
- 4
Klempnauer J. et al. .
Transplantationsmedizin - (15. Jahrestagung der Deutschen Transplantationsgesellschaft
am 21. München).
2006;
18
48-49
- 5
Krämer BK, Zulke C, Kammerl MC. et al. .
Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing
calcineurin inhibitors in renal transplantation.
Am J Transplant.
2003;
3
982-987
- 6
Ligtenberg G, Hene RJ, Blankestijn PJ, Koomans HA..
Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus.
J Am Soc Nephr.
2001;
12
368-373
- 7
Margreiter R. et al. .
Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal
transplantation: a randomised multicentre study.
Lancet.
2002;
359
741-746
- 8
Mayer AD..
Chronic rejection and graft half-life: five-year follow-up of the European Tacrolimus
Multicenter Renal Study.
Transplant Proc.
2002;
34
1491-1492
- 9
Meier-Kriesche HU, Li S, Gruessner RW. et al. .
Immunosuppression: evolution in practice and trends, 1994-2004.
Am J Transplant.
2006;
6
1111-1131
- 10
Vincenti F, Jensik SC, Filo RS. et al. .
A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation:
evidence for improved allograft survival at five years.
Transplantation.
2002;
73
775-782
- 11
Webster AC, Woodroffe RC, Taylor RS. et al. .
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients:
meta-analysis and meta-regression of randomised trial data.
BMJ.
2005;
331
810-814
1 Efficacy Limiting Toxicity Elimination
